Nephros (NEPH) Cash from Financing Activities (2010 - 2026)
Nephros (NEPH) posted quarterly Cash from Financing Activities of $289000.0 for Q1 2026, up 29000.0% year-over-year from N/an in Q1 2025, and up 29000.0% quarter-over-quarter from -$1000.0 in Q4 2025.
Nephros (NEPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Nephros' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $289000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 29000.0% year-over-year to $289000.0; the TTM figure through Mar 2026 stood at $285000.0 (up 7225.0% YoY), while the FY2025 annual figure was -$5000.0, changed 0.0% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at $289000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $289000.0 in Q1 2026, with the low at -$111000.0 in Q4 2022.
- The 5-year median for Cash from Financing Activities is -$2000.0 (2023), against an average of $15600.0.
- The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities sank 250.0% in 2022, then jumped 29000.0% in 2026.
- Nephros' Cash from Financing Activities stood at -$111000.0 in 2022, then soared by 97.3% to -$3000.0 in 2023, then soared by 66.67% to -$1000.0 in 2024, then changed by 0.0% to -$1000.0 in 2025, then surged by 29000.0% to $289000.0 in 2026.
- Business Quant data shows NEPH's Cash from Financing Activities at $289000.0 in Q1 2026, -$1000.0 in Q4 2025, and -$2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -287.90 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -577.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -510.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -263.16 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -159.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -300.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -75.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -31.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2,000.00 |
| Jun 30, 2026 | -2,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Mar 31, 2026 | 289,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Dec 31, 2025 | -1,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Jun 30, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | -3,000.00 |
| Dec 31, 2023 | -3,000.00 |